Esmee C M Kooijmans, Helena J H van der Pal, Saskia M F Pluijm, Margriet van der Heiden-van der Loo, Leontien C M Kremer, Dorine Bresters, Eline van Dulmen-den Broeder, Marry M van den Heuvel-Eibrink, Jacqueline J Loonen, Marloes Louwerens, Sebastian J C Neggers, Cécile Ronckers, Wim J E Tissing, Andrica C H de Vries, Gertjan J L Kaspers, Margreet A Veening, Arend Bökenkamp
This investigation aimed to evaluate glomerular dysfunction among childhood cancer survivors in comparison with matched controls from the general population. In the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis, a nationwide cross-sectional cohort study, 1024 survivors five or more years after diagnosis, aged 18 or more years at study, treated between 1963-2001 with nephrectomy, abdominal radiotherapy, total body irradiation, cisplatin, carboplatin, ifosfamide, high-dose cyclophosphamide or hematopoietic stem cell transplantation participated...
November 2022: Kidney International